Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Review

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal

      
Total article views   HTML views PDF downloads Totals
8,123 Dovepress* 6,695+ 1,066 7,761
PubMed Central* 1,428 280 1,708
Totals 8,123 1,346 9,469
*Since 22 August 2018

View citations on PubMed Central and Google Scholar